Best in 7 days BPC-157 And TB-500: Background, Indications, Efficacy, And Safety GlobalRPH US$ 26.46 Sold : Login>>
Pressure rises on Novo as Innovent drug tops Ozempic US$ 27.02 Min. order: 1 piece ★★★★★ 4.3 (44 reviews) Sold : Login>>
GLP-1-based therapies for diabetes, obesity and beyond US$ 24.60 Min. order: 1 piece ★★★★★ 4.2 (75 reviews) Sold : Login>>
New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists US$ 23.73 Min. order: 1 piece ★★★★★ 4.7 (203 reviews) Sold : Login>>
BPC 157 Banned: Key Facts on the Latest FDA Decision US$ 20.54 Min. order: 1 piece ★★★★★ 4.9 (160 reviews) Sold : Login>>
Once-weekly mazdutide, a glucagon-like peptide-1 and glucagon receptor dual agonist, provided clinically relevant reduction in body weight in Chinese adults with obesity or overweight. Full GLORY-1 trial results: https://nej.md/4koUvaP US$ 26.65 Min. order: 1 piece ★★★★★ 4.0 (77 reviews) Sold : Login>>